Back to Journals » Patient Preference and Adherence » Volume 2

New and emerging trends in the treatment of atopic dermatitis

Authors Gelbard CM, Hebert AA

Published 21 January 2009 Volume 2008:2 Pages 387—392

DOI https://doi.org/10.2147/PPA.S3345

Review by Single-blind

Peer reviewer comments 1

Christina M Gelbard1, Adelaide A Hebert1,2

1Departments of Dermatology; 2Pediatrics, University of Texas-Houston, Houston, TX, USA

Abstract: Atopic dermatitis is a chronic, inflammatory skin condition that affects 10% to 20% of children and 1% to 3% of adults in the US. Symptoms often result in sleeplessness, psychological stress, poor self-esteem, anxiety, and poor school or work performance. The cost of atopic dermatitis is estimated to be US$0.9 to 3.8 billion every year. Topical steroids are first-line treatment for atopic dermatitis, and recent advances in vehicle technologies have resulted in improved patient tolerability and compliance. Topical calcineurin inhibitors are also safe and effective topical treatments for atopic dermatitis, and provide an additional therapeutic option for patients with this disease. Systemic immunomodulators are used in the treatment of severe refractory disease. Cyclosporine, methotrexate, azathioprine, mycophenolate mofetil, and interferon gamma have been used in the management of severe atopic dermatitis. This review highlights the current and emerging trends in the treatment of atopic dermatitis.

Keywords: atopic dermatitis, topical corticosteroids, calcineurin inhibitors, methotrexate, cyclosporine, mycophenolate mofetil, IFN-γ

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Nursing faculty teaching a module in clinical skills to medical students: a Lebanese experience

Abdallah B, Irani J, Sailian SD, Gebran VG, Rizk U

Advances in Medical Education and Practice 2014, 5:427-432

Published Date: 13 November 2014

Identification of primary care patients at risk of nonadherence to antidepressant treatment

Ann-Charlotte Åkerblad, Finn Bengtsson, Margareta Holgersson, Lars von Knorring, Lisa Ekselius

Patient Preference and Adherence 2008, 2:379-386

Published Date: 8 January 2009

Brief report: Characteristics of antidepressant use in patients with heart failure

Paul J Mills, Joel E Dimsdale, Suzi Hong, Geoffrey Van Den Brande, Laura Redwine, et al

Patient Preference and Adherence 2008, 2:333-336

Published Date: 11 November 2008

Are symbols useful and culturally acceptable in health-state valuation studies? An exploratory study in a multi-ethnic Asian population

Hwee-Lin, Wee, Shu-Chuen Li, Xu-Hao Zhang, Feng Xie, David Feeny, et al

Patient Preference and Adherence 2008, 2:271-276

Published Date: 2 October 2008

Comparison of persistence rates of acetylcholine-esterase inhibitors in a state Medicaid program

Susan M Abughosh, Stephen J Kogut

Patient Preference and Adherence 2008, 2:79-85

Published Date: 20 March 2008

Medication adherence among heart and/or lung transplant recipients: An exploratory study

Rebecca A O’Brien, Parisa Aslani, Maria A Ciccia, Jo-anne E Brien

Patient Preference and Adherence 2008, 2:115-120

Published Date: 20 March 2008